Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Лечение морбидного ожирения у взрослых

Список литературы | REFERENCES

  1. World Health Organization. Obesity: preventing and managing the global epidemic. 1997, Geneva:WHO http://www.who.int/nutrition/ publications/obesity/WHO_TRS_894/en/
  2. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am. J. Clin. Nutr. 1992;55(2 Suppl):615S-619S.
  3. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes. Res. 1998;6 Suppl 2:51S-209S.
  4. Cefalu WT, Bray GA, Home PD, et al. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflec- tions From aDiabetes CareEditors’ Expert Forum. Diabetes Care. 2015;38(8):1567-1582. doi: 10.2337/dc15-1081.
  5. Eckel RH. Obesity: Mechanisms and Clinical Management: Lippincott Williams & Wilkins; 2003.
  6. Kannel WB, D’Agostino RB, Cobb JL. Effect of weight on car- diovascular disease. The American Journal of Clinical Nutrition. 1996;63(3):419S-422S. doi: 10.1093/ajcn/63.3.419.
  7. Shaper AG, Wannamethee SG, Walker M. Body weight: implica- tions for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ. 1997;314(7090):1311-1311. doi: 10.1136/bmj.314.7090.1311.
  8. Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a nationwide US cohort. Int. J. Obes. 2006;30(5):822-829. doi: 10.1038/sj.ijo.0803193.
  9. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: A systematic review and me- ta-analysis. BMC Public Health. 2009;9(1). doi: 10.1186/1471-2458-9-88.
  10. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int. 2009;106(40):641-648. doi: 10.3238/arz- tebl.2009.0641.
  11. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brus- sels, Belgium: International Diabetes Federation, 2017. http://www. diabetesatlas.org
  12. Dedov I, Shestakova M, Benedetti MM, et al. Prevalence of type 2 diabetes mellitus (T2DM) in the adult Russian population (NATION study). Diabetes Res. Clin. Pract. 2016;115:90-95. doi: 10.1016/j.dia-bres.2016.02.010.
  13. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery. JAMA. 2004;292(14):1724. doi: 10.1001/jama.292.14.1724. World Health Organization. Global Health Risks: mortality and burden of disease attributable to selected major risks. (2009). http://www. who.int/healthinfo/global_burden_disease/global_health_risks/en/ ndex.html.
  14. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом / Под редакцией И.И. Дедова, М.В. Шестаковой,
  15. А.Ю. Майорова. – 8-й выпуск // Сахарный диабет. – 2017. – Т. 20. – №1S. – C. 1-121. [Dedov II, Shestakova MV, Mayorov AY, et al.
  16. Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th edition.Diabetes mellitus. 2017;20(1S):1-121. (In Russ)] doi: 10.14341/DM20171S8
  17. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guide- lines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by american association of clinical endocrinologists, The obesi- y society, and american society fo. Obesity. 2013;21(S1):S1-S27. doi: 10.1002/oby.20461.
  18. Garvey WT, Mechanick JI, Brett EM, et al. American Association of
  19. Clinical Endocrinologists and American College of Endocrinology
  20. Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr. Pract. 2016;22(Supplement 3):1-203. doi: 10.4158/ep161365.gl.
  21. Bernstein DP. Cardiovascular physiology. In Morbid Obesity. Periop- erative management. Edited by Alvarez A. 2nd Edition. Cambridge University Press 2010
  22. Lemmens HJM. Perioperative pharmacology in morbid obe- sity. Current Opinion in Anaesthesiology. 2010;23(4):485-491. doi: 10.1097/ACO.0b013e32833b0a8c.
  23. Fried M, Yumuk V, Oppert J-M, et al. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery. Obesity Facts. 2013;6(5):449-468. doi: 10.1159/000355480.
  24. Network SIG. 73: Management of obstructive sleep apnoea/hypopnoea syndrome in adults. A National Clinical Guideline. Edinburgh: SIGN. 2003.
  25. Kushida CA, Littner MR, Morgenthaler T, et al. Practice Parameters for the Indications for Polysomnography and Related Procedures: An Up- date for 2005. Sleep. 2005;28(4):499-523. doi: 10.1093/sleep/28.4.499.
  26. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice Parameters for the Use of Continuous and Bilevel Positive Airway Pressure Devices to Treat Adult Patients With Sleep-Related Breathing Disorders. Sleep. 2006;29(3):375-380. doi: 10.1093/sleep/29.3.375.
  27. Screening for obstructive sleep apnea in the primary care setting. University of Texas at Austin School of Nursing, Family Nurse Practi- tioner Program – Academic Institution. 2006.
  28. Avenell A, Brown TJ, McGee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. Journal of Human Nutrition and Dietetics. 2004;17(4):317-335. doi: 10.1111/j.1365-277X.2004.00531.x.
  29. Pate RR. Physical Activity and Public Health. JAMA. 1995;273(5):402. doi: 10.1001/jama.1995.03520290054029.
  30. Warburton DER. Health benefits of physical activity: the evidence. Can. Med. Assoc. J. 2006;174(6):801-809. doi: 10.1503/cmaj.051351.
  31. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight- loss maintenance: a meta-analysis of US studies. The American Journal of Clinical Nutrition. 2001;74(5):579-584. doi: 10.1093/ajcn/74.5.579.
  32. Guidelines for Laparoscopic and Open Surgical Treat- ment of Morbid Obesity. Obes. Surg. 2000;10(4):378-379. doi: 10.1381/096089200321629184.
  33. American College of Endocrinology (ACE), American Association of Clinical Endocrinologists (AACE): AACE/ACE position statement on the prevention, diagnosis and treatment of obesity. Jacksonville, American Association of Clinical Endocrinologists, 1998.
  34. Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabe- tes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine. 2009;122(3):248-256.e245. doi: 10.1016/j.amjmed.2008.09.041.
  35. Rucker D, Padwal R, Li SK, et al. Long term pharmacothera- py for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194-1199. doi: 10.1136/bmj.39385.413113.25.
  36. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. 2004. In: NIHR Health Technology Assessment programme: Executive Summaries. Southampton (UK): NIHR Journals Library; 2003-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK62231/
  37. Sjöström L, Rissanen A, Andersen T, et al. Randomised placebo-con- trolled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet. 1998;352(9123):167-172. doi: 10.1016/s0140-6736(97)11509-4.
  38. Didangelos TP, Thanopoulou AK, Bousboulas SH, et al. The ORlistat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORliCARDIA) study. Curr. Med. Res. Opin. 2004;20(9):1393-1401. doi: 10.1185/030079904125004466.
  39. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2003;27(1):155-161. doi: 10.2337/diacare.27.1.155.
  40. Wirth A. Reduction of body weight and co-morbidities by orlistat: The XXL – Primary Health Care Trial. Diabetes, Obesity and Metabolism. 2005;7(1):21-27. doi: 10.1111/j.1463-1326.2004.00428.x.
  41. Williamson DF, Pamuk E, Thun M, et al. Prospective Study of Intentional Weight Loss and Mortality in Overweight White Men Aged 40-64 Years. Am. J. Epidemiol. 1999;149(6):491-503. doi: 10.1093/oxfordjournals.aje.a009843.
  42. Curfman GD, Morrissey S, Drazen JM. Sibutramine — An- other Flawed Diet Pill. N. Engl. J. Med. 2010;363(10):972-974. doi: 10.1056/NEJMe1007993.
  43. James WPT, Caterson ID, Coutinho W, et al. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects. N. Engl. J. Med. 2010;363(10):905-917. doi: 10.1056/NEJMoa1003114.
  44. Astrup A, Carraro R, Finer N, et al. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int. J. Obes. 2011;36(6):843-854. doi: 10.1038/ijo.2011.158.
  45. Kofman MD, Lent MR, Swencionis C. Maladaptive Eating Patterns, Quality of Life, and Weight Outcomes Following Gastric Bypass: Results of an Internet Survey. Obesity. 2010;18(10):1938-1943. doi: 10.1038/oby.2010.27.
  46. Odom J, Zalesin KC, Washington TL, et al. Behavioral Predictors of Weight Regain after Bariatric Surgery. Obes. Surg. 2009;20(3):349-356. doi: 10.1007/s11695-009-9895-6.
  47. Colles SL, Dixon JB, O'Brien PE. Grazing and Loss of Control Related to Eating: Two High-risk Factors Following Bariatric Surgery. Obesity. 2008;16(3):615-622. doi: 10.1038/oby.2007.101.
  48. Kruseman M, Leimgruber A, Zumbach F, Golay A. Dietary, Weight, and Psychological Changes among Patients with Obesity, 8 Years after Gastric Bypass. J. Am. Diet. Assoc. 2010;110(4):527-534. doi: 10.1016/j.jada.2009.12.028.
  49. de Zwaan M, Mitchell JE, Howell LM, et al. Characteristics of morbidly obese patients before gastric bypass surgery. Compr. Psychiatry. 2003;44(5):428-434. doi: 10.1016/s0010-440x(03)00092-0.
  50. Arterburn DE, Bogart A, Sherwood NE, et al. A Multisite Study of Long-term Remission and Relapse of Type 2 Diabetes Mel- litus Following Gastric Bypass. Obes. Surg. 2012;23(1):93-102. doi: 10.1007/s11695-012-0802-1.
  51. Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy. Ann. Surg. 2009;250(2):234-241. doi: 10.1097/SLA.0b013e3181ae32e3.
  52. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35(6):518-523. doi: 10.1016/s1262-3636(09)73459-7.
  53. Garb J, Welch G, Zagarins S, et al. Bariatric Surgery for the Treatment of Morbid Obesity: A Meta-analysis of Weight Loss Outcomes for Laparoscopic Adjustable Gastric Banding and Laparoscopic Gastric Bypass. Obes. Surg. 2009;19(10):1447-1455. doi: 10.1007/s11695-009-9927-2.
  54. Valezi AC, Junior JM, de Menezes MA, et al. Weight Loss Outcome Af- ter Silastic Ring Roux-en-Y Gastric Bypass: 8 Years of Follow-up. Obes. Surg. 2010;20(11):1491-1495. doi: 10.1007/s11695-010-0264-2.
  55. Toouli J, Kow L, Ramos AC, et al. International multicenter study of safety and effectiveness of Swedish Adjustable Gastric Band in 1-, 3-, and 5-year follow-up cohorts. Surg. Obes. Relat. Dis. 2009;5(5):598-609. doi: 10.1016/j.soard.2009.04.012.
  56. Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabe- tes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine. 2009;122(3):248-256.e245. doi: 10.1016/j.amjmed.2008.09.041.
  57. Hofso D, Nordstrand N, Johnson LK, et al. Obesity-related cardio- vascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. European journal of endocrinology / European Federation of Endocrine Societies. 2010;163(5):735-745. doi: 10.1530/eje-10-0514.
  58. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric Surgery versus Inten- sive Medical Therapy in Obese Patients with Diabetes. N. Engl. J. Med. 2012;366(17):1567-1576. doi: 10.1056/NEJMoa1200225.
  59. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes. N. Engl. J. Med. 2012;366(17):1577-1585. doi: 10.1056/NEJMoa1200111.
  60. Hofso D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. European journal of endocrinology / European Federation of Endocrine Societies. 2010;164(2):231-238. doi: 10.1530/eje-10-0804.
  61. Hsu LKG, Benotti PN, Dwyer J, et al. Nonsurgical Factors That Influence the Outcome of Bariatric Surgery. Psychosom. Med. 1998;60(3):338-346. doi: 10.1097/00006842-199805000-00021.
  62. Herpertz S, Kielmann R, Wolf AM, et al. Do Psychosocial Vari- ables Predict Weight Loss or Mental Health after Obesity Sur- gery? A Systematic Review. Obes. Res. 2004;12(10):1554-1569. doi: 10.1038/oby.2004.195.
  63. Kalarchian MA, Marcus MD, Levine MD, et al. Relationship of psychi- atric disorders to 6-month outcomes after gastric bypass. Surg. Obes. Relat. Dis. 2008;4(4):544-549. doi: 10.1016/j.soard.2008.03.003.
  64. Tindle HA, Omalu B, Courcoulas A, et al. Risk of Suicide after Long- term Follow-up from Bariatric Surgery. The American Journal of Medi- cine. 2010;123(11):1036-1042. doi: 10.1016/j.amjmed.2010.06.016.
  65. Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric Diagnoses and Psychiatric Treatment Among Bariatric Surgery Candidates. Obes. Surg. 2004;14(9):1148-1156. doi: 10.1381/0960892042386922.
  66. van Hout GCM, Verschure SKM, Van Heck GL. Psychosocial Predictors of Success following Bariatric Surgery. Obes. Surg. 2005;15(4):552-560. doi: 10.1381/0960892053723484.
  67. Wadden TA, Sarwer DB. Behavioral Assessment of Candidates for Bariatric Surgery: A Patient-Oriented Approach. Obesity. 2006;14(3S):53S-62S. doi: 10.1038/oby.2006.283.
  68. Handelsman Y, Bloomgarden ZT, Grunberger G, et al. American Association of Clinical Endocrinologists and American College of En- docrinology – Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan – 2015 —Executive Summary. Endocr. Pract. 2015;21(4):413-437. doi: 10.4158/ep15672.gl.
  69. Dronge AS. Long-term Glycemic Control and Postopera- tive Infectious Complications. Arch. Surg. 2006;141(4):375. doi: 10.1001/archsurg.141.4.375.
  70. Geerts WH, Pineo GF, Heit JA, et al. Prevention of Ve- nous Thromboembolism. Chest. 2004;126(3):338S-400S. doi: 10.1378/chest.126.3_suppl.338S.
  71. Yang C-S, Lee W-J, Wang H-H, et al. The Influence of Helicobacter pylori Infection on the Development of Gastric Ulcer in Symptom- atic Patients after Bariatric Surgery. Obes. Surg. 2006;16(6):735-739. doi: 10.1381/096089206777346754.
  72. Reoch J. Safety of Laparoscopic vs Open Bariatric Surgery. Arch. Surg. 2011;146(11):1314. doi: 10.1001/archsurg.2011.270.
  73. Polk Jr HC, Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections. The American Surgeon. 2000;66(2):105.
  74. Mognol P, Vignes S, Chosidow D, Marmuse J-P. Rhabdomyolysis after Laparoscopic Bariatric Surgery. Obes. Surg. 2004;14(1):91-94. doi: 10.1381/096089204772787356.
  75. de Freitas Carvalho D, Valezi A, de Brito E, et al. Rhabdomyoly- sis after Bariatric Surgery. Obes. Surg. 2006;16(6):740-744. doi: 10.1381/096089206777346655.
  76. Favretti F, O’Brien PE, Dixon JB. Patient management after LAP-BAND placement. The American Journal of Surgery. 2002;184(6):S38-S41. doi: 10.1016/s0002-9610(02)01178-9.
  77. Dixon AFR, Dixon JB, O’Brien PE. Laparoscopic Adjustable Gas- tric Banding Induces Prolonged Satiety: A Randomized Blind Crossover Study. J. Clin. Endocr. Metab. 2005;90(2):813-819. doi: 10.1210/jc.2004-1546.
  78. Brolin RE, Robertson LB, Kenler HA, Cody RP. Weight Loss and Dietary Intake After Vertical Banded Gastroplasty and Roux-en-Y Gastric Bypass. Ann. Surg. 1994;220(6):782-790. doi: 10.1097/00000658-199412000-00012.
  79. Stocker DJ. Management of the bariatric surgery patient. Endocrinol. Metab. Clin. North Am. 2003;32(2):437-457. doi: 10.1016/s0889-8529(03)00002-1.
  80. Brolin RE, Kenler HA, Wilson AC, et al. Serum lipids after gastric bypass surgery for morbid obesity. Int. J. Obes. 1990;14(11):939-950.
  81. Brolin R. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J. Gastrointest. Surg. 2000;4(5):464-469. doi: 10.1016/s1091-255x(00)80087-6.
  82. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic Hypo- glycemia with Nesidioblastosis after Gastric-Bypass Surgery. N. Engl. J. Med. 2005;353(3):249-254. doi: 10.1056/NEJMoa043690.
  83. Goldfine AB, Mun EC, Devine E, et al. Patients with Neuroglyco- penia after Gastric Bypass Surgery Have Exaggerated Incretin and Insulin Secretory Responses to a Mixed Meal. J. Clin. Endocr. Metab. 2007;92(12):4678-4685. doi: 10.1210/jc.2007-0918.
  84. Martin L. Pregnancy after adjustable gastric banding*1. Obstet. Gyne- col. 2000;95(6):927-930. doi: 10.1016/s0029-7844(00)00819-x.
  85. Gerrits EG, Ceulemans R, van Hee R, et al. Contraceptive Treat- ment after Biliopancreatic Diversion Needs Consensus. Obes. Surg. 2003;13(3):378-382. doi: 10.1381/096089203765887697.
  86. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endo- crine Society Clinical Practice Guideline. J. Clin. Endocr. Metab. 2010;95(11):4823-4843. doi: 10.1210/jc.2009-2128.
  87. Brolin RE, Leung M. Survey of Vitamin and Mineral Supplementation after Gastric Bypass and Biliopancreatic Diversion for Morbid Obesity. Obes. Surg. 1999;9(2):150-154. doi: 10.1381/096089299765553395.
  88. Skroubis G, Sakellaropoulos G, Pouggouras K, et al. Comparison of Nutritional Deficiencies after Rouxen-Y Gastric Bypass and after Biliopancreatic Diversion with Roux-en-Y Gastric Bypass. Obes. Surg. 2002;12(4):551-558. doi: 10.1381/096089202762252334.
  89. Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevent- ed by standard multivitamin supplementation. The American Journal of Clinical Nutrition. 2008;87(5):1128-1133. doi: 10.1093/ajcn/87.5.1128.
  90. Aasheim ET, Hofsø D, Hjelmesæth J, et al. Vitamin status in morbidly obese patients: a cross-sectional study. The American Journal of Clini- cal Nutrition. 2008;87(2):362-369. doi: 10.1093/ajcn/87.2.362.
  91. Ybarra J, Sánchez-Hernández J, Pérez A. Hypovitaminosis D and Morbid Obesity. Nurs. Clin. North Am. 2007;42(1):19-27. doi: 10.1016/j.cnur.2006.12.001.
  92. Carlin A, Rao D, Meslemani A, et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg. Obes. Relat. Dis. 2006;2(2):98-103. doi: 10.1016/j.soard.2005.12.001.
  93. Snijder MB, van Dam RM, Visser M, et al. Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Popula- tion-Based Study in Older Men and Women. J. Clin. Endocr. Metab. 2005;90(7):4119-4123. doi: 10.1210/jc.2005-0216.
  94. Hamoui N. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch. Surg. 2003;138(8):891. doi: 10.1001/archsurg.138.8.891.
  95. Hjelmesæth J, Hofsø D, Aasheim ET, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc. Diabetol. 2009;8(1):7. doi: 10.1186/1475-2840-8-7.
  96. Goldner WS, Stoner JA, Lyden E, et al. Finding the Optimal Dose of Vitamin D Following Roux-en-Y Gastric Bypass: A Prospective, Randomized Pilot Clinical Trial. Obes. Surg. 2008;19(2):173-179. doi: 10.1007/s11695-008-9680-y.
  97. Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D deple- tion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg. Obes. Relat. Dis. 2009;5(4):444-449. doi: 10.1016/j. soard.2008.08.004.
  98. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocr. Metab. 2011;96(7):1911-1930. doi: 10.1210/jc.2011-0385.
  99. Остеопороз. Диагностика, профилактика и лечение Москва, 2010, Клинические рекомендации Российской ассоциации по остеопорозу (Второе издание, переработанное и дополненное). [Osteo- poroz. Diagnostika, profilaktika i lechenie Moskva, 2010, Klinicheskie rekomendatsii Rossiyskoy assotsiatsii po osteoporozu (Vtoroe izdanie, pererabotannoe i dopolnennoe). (In Russ)] Available from: https:// www.endocrincentr.ru/sites/default/files/specialists/science/clin- ic-recomendations/rec_osteoporosis_2016.pdf
  100. Rosen CJ, Brown S. Severe Hypocalcemia after Intravenous Bisphos- phonate Therapy in Occult Vitamin D Deficiency. N. Engl. J. Med. 2003;348(15):1503-1504. doi: 10.1056/nejm200304103481521.
  101. Collazo-Clavell M., Jimenez A., Hodson S. et al. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 2004; 10: 195-198
  102. Maricic M. New and emerging treatments for osteoporosis. Curr. Opin. Rheumatol. 2007;19(4):364-369. doi: 10.1097/BOR.0b013e328172dc1a.
  103. Brolin RE, Leung M. Survey of Vitamin and Mineral Supplementation after Gastric Bypass and Biliopancreatic Diversion for Morbid Obesity. Obes. Surg. 1999;9(2):150-154. doi: 10.1381/096089299765553395.
  104. Brolin RE, Gorman JH, Gorman RC, et al. Prophylactic Iron Supple- mentation After Roux-en-Y Gastric Bypass. Arch. Surg. 1998;133(7). doi: 10.1001/archsurg.133.7.740.
  105. Rhode BM, Arseneau P, Cooper BA, et al. Vitamin B-12 deficiency after gastric surgery for obesity. The American Journal of Clinical Nutrition. 1996;63(1):103-109. doi: 10.1093/ajcn/63.1.103.
  106. Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet. 2017;390(10113):2627-2642. doi: 10.1016/s0140-6736(17)32129-3.
  107. Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabe- tes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine. 2009;122(3):248-256.e245. doi: 10.1016/j.amjmed.2008.09.041.
  108. Busetto L, Dixon J, De Luca M, et al. Bariatric Surgery in Class I Obesi- ty. Obes. Surg. 2014;24(4):487-519. doi: 10.1007/s11695-014-1214-1.
  109. Apovian CM, Baker C, Ludwig DS, et al. Best Practice Guide- lines in Pediatric/Adolescent Weight Loss Surgery. Obes. Res. 2005;13(2):274-282. doi: 10.1038/oby.2005.37.
  110. Inge TH. Bariatric Surgery for Severely Overweight Adolescents: Concerns and Recommendations. Pediatrics. 2004;114(1):217-223. doi: 10.1542/peds.114.1.217.
  111. Sugerman H. Bariatric Surgery for Severely Obese Adolescents. J. Gastrointest. Surg. 2003;7(1):102-108. doi: 10.1016/s1091- 255x(02)00125-7.
  112. Dolan K, Creighton L, Hopkins G, Fielding G. Laparoscopic Gastric Banding in Morbidly Obese Adolescents. Obes. Surg. 2003;13(1):101-104. doi: 10.1381/096089203321136674.
  113. Stanford A, Glascock JM, Eid GM, et al. Laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. J. Pediatr. Surg. 2003;38(3):430-433. doi: 10.1053/jpsu.2003.50074.
  114. Widhalm K, Dietrich S, Prager G. Adjustable gastric banding surgery in morbidly obese adolescents: experiences with eight patients. Int. J. Obes. 2004;28(S3):S42-S45. doi: 10.1038/sj.ijo.0802813.
  115. Silberhumer G, Miller K, Kriwanek S, et al. Laparoscopic Adjustable Gastric Banding in Adolescents: The Austrian Experience. Obes. Surg. 2006;16(8):1062-1067. doi: 10.1381/096089206778026262.
  116. Capella JF, Capella RF. Bariatric Surgery in Adolescence. Is this the Best Age to Operate? Obes. Surg. 2003;13(6):826-832. doi: 10.1381/096089203322618597.
  117. Hofso D, Jenssen T, Bollerslev J, et al. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. European journal of endocrinology / European Federation of Endocrine Societies. 2010;164(2):231-238. doi: 10.1530/eje-10-0804.
  118. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable Gastric Banding and Conventional Therapy for Type 2 Diabetes. JAMA. 2008;299(3). doi: 10.1001/jama.299.3.316.
  119. Lee W-J. Gastric Bypass vs Sleeve Gastrectomy for Type 2 Diabetes Mellitus. Arch. Surg. 2011;146(2):143. doi: 10.1001/archsurg.2010.326.
  120. Lee W-J, Wang W, Lee Y-C, et al. Effect of Laparoscopic Mini-Gas- tric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI >35 and <35 kg/m2. J. Gastrointest. Surg. 2007;12(5):945-952. doi: 10.1007/s11605-007-0319-4.
  121. Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care. 2012;35(7):1420-1428. doi: 10.2337/dc11-2289.
  122. Choi J, Digiorgi M, Milone L, et al. Outcomes of laparoscopic adjust- able gastric banding in patients with low body mass index. Surg. Obes. Relat. Dis. 2010;6(4):367-371. doi: 10.1016/j.soard.2009.09.021.
  123. Serrot FJ, Dorman RB, Miller CJ, et al. Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2. Surgery. 2011;150(4):684-691. doi: 10.1016/j.surg.2011.07.069.
  124. Fried M, Ribaric G, Buchwald JN, et al. Metabolic Surgery for the Treatment of Type 2 Diabetes in Patients with BMI <35 kg/m2: An Integrative Review of Early Studies. Obes. Surg. 2010;20(6):776-790. doi: 10.1007/s11695-010-0113-3.
  125. Lee W-J, Chong K, Chen C-Y, et al. Diabetes Remission and Insulin Se- cretion After Gastric Bypass in Patients with Body Mass Index <35 kg/ m2. Obes. Surg. 2011;21(7):889-895. doi: 10.1007/s11695-011-0401-6.
  126. DeMaria EJ, Winegar DA, Pate VW, et al. Early Postoperative Outcomes of Metabolic Surgery to Treat Diabetes From Sites Participating in the ASMBS Bariatric Surgery Center of Excellence Program as Reported in the Bariatric Outcomes Longitudinal Database. Transactions of the ... Meeting of the American Surgical Association. 2010;128:166-175. doi: 10.1097/SLA.0b013e3181f2aed0.
  127. Lee W-J, Ser K-H, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: Efficacy and change of insulin secretion. Surgery. 2010;147(5):664-669. doi: 10.1016/j.surg.2009.10.059.
  128. Buse JB, Caprio S, Cefalu WT, et al. How Do We Define Cure of Diabe- tes? Diabetes Care. 2009;32(11):2133-2135. doi: 10.2337/dc09-9036.
  129. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric Surgery for Weight Loss and Glycemic Control in Nonmor- bidly Obese Adults With Diabetes. JAMA. 2013;309(21):2250. doi: 10.1001/jama.2013.4851.
  130. Skrekas G, Antiochos K, Stafyla VK. Laparoscopic Gastric Greater Cur- vature Plication: Results and Complications in a Series of 135 Patients. Obes. Surg. 2011;21(11):1657-1663. doi: 10.1007/s11695-011-0499-6.
  131. Ramos A, Galvao Neto M, Galvao M, et al. Laparoscopic Great- er Curvature Plication: Initial Results of an Alternative Re- strictive Bariatric Procedure. Obes. Surg. 2010;20(7):913-918. doi: 10.1007/s11695-010-0132-0.
  132. Brethauer SA, Harris JL, Kroh M, Schauer PR. Laparoscopic gastric plication for treatment of severe obesity. Surg. Obes. Relat. Dis. 2011;7(1):15-22. doi: 10.1016/j.soard.2010.09.023.
  133. National Institute for Health and Clinical Excellence (NICE) Interven- tional Procedure Guidance 432: Laparoscopic gastric plication for the treatment of severe obesity. www.guidance.nice.org.uk/pg432, 2012
  134. Fried M, Dolezalova K, Buchwald JN, et al. Laparoscopic Great- er Curvature Plication (LGCP) for Treatment of Morbid Obesity in a Series of 244 Patients. Obes. Surg. 2012;22(8):1298-1307. doi: 10.1007/s11695-012-0684-2.
  135. Bavaresco M, Paganini S, Lima TP, et al. Nutritional Course of Patients Submitted to Bariatric Surgery. Obes. Surg. 2008;20(6):716-721. doi: 10.1007/s11695-008-9721-6.
  136. Andreu A, Moizé V, Rodríguez L, et al. Protein Intake, Body Compo- sition, and Protein Status Following Bariatric Surgery. Obes. Surg. 2010;20(11):1509-1515. doi: 10.1007/s11695-010-0268-y.
  137. Moizé VL, Pi-Sunyer X, Mochari H, Vidal J. Nutritional Pyramid for Post-gastric Bypass Patients. Obes. Surg. 2010;20(8):1133-1141. doi: 10.1007/s11695-010-0160-9.
  138. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorp- tion following bariatric surgery and its theoretical implications. Obes. Rev. 2010;11(1):41-50. doi: 10.1111/j.1467-789X.2009.00614.x.
  139. Miller AD. Medication and nutrient administration considerations af- ter bariatric surgery. Am. J. Health Syst. Pharm. 2006;63(19):1852-1857. doi: 10.2146/ajhp060033.
  140. Carron M, Veronese S, Foletto M, Ori C. Sugammadex Allows Fast-Track Bariatric Surgery. Obes. Surg. 2013;23(10):1558-1563. doi: 10.1007/s11695-013-0926-y.
  141. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthe- sia. Br. J. Anaesth. 2012;108(2):236-239. doi: 10.1093/bja/aer330.
  142. Carron M, Gasparetto M, Vindigni V, Foletto M. Laparoscopic surgery in a morbidly obese, high-risk cardiac patient: the benefits of deep neuromuscular block and sugammadex. Br. J. Anaesth. 2014;113(1):186-187. doi: 10.1093/bja/aeu211.
  143. Olesnicky BL, Traill C, Marroquin-Harris FB. The effect of routine avail- ability of sugammadex on postoperative respiratory complications: a historical cohort study. Minerva Anestesiol. 2017;83(3):248 – 254. doi: 10.23736/s0375-9393.16.11489-0.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы | REFERENCES
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*